Aeras, the non-profit organisation working out of bases in both the US and South Africa, has received a grant up to $220 million over five years from the Bill and Melinda Gates Foundation for further development of new vaccines for tuberculosis (TB). The grant extends the Gates Foundation's long time backing of Aeras, which has also received funds from government bodies.
Focusing exclusively on TB, the non-profit has a pipeline of candidates being developed through pharmaceutical and academic partnerships,. "We have...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?